Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Anticancer drug R&D landscape in China

Fig. 1

Phase 1 oncology pipeline, targets, and studied cancer types. a Overall phase 1 pipeline. b Cell therapy pipeline. c Top 30 targets in the phase 1 pipeline. d Most studied cancer types in phase 1 trials and changes relative to 2017

Back to article page